Clarus Therapeutics

United States
Attalla, Alabama, United States
847-562-4300 ★

Company profile

Clarus Therapeutics company profile

Clarus Therapeutics is a biopharmaceutical company that develops androgen-based medicines for men and women. It offers OriTex, a proprietary oral testosterone product for use in men with low testosterone levels.

Business identity

Contact email
[email protected]
Phone number
847-562-4300
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$10K+
Founded
2003-01-01

Headquarters

Headquarters
Attalla, Alabama, United States
Postal code
60062
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
8
Total equity funding
$112M
Last funding
Post Ipo Equity / $30M / 2022-04-25
Last equity funding
Post Ipo Equity / $30M
Investors
4
Lead investors
3
Founders
1
Articles
30
Exited on
2021-09-10

Founders and investors

Founders

Robert E. Dudley

Lead investors

C-Bridge CapitalH.I.G. CapitalThomas, McNerney & Partners

Investors

Armentum PartnersC-Bridge CapitalH.I.G. CapitalThomas, McNerney & Partners

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.